Clinical utility of 99mTc-ubiquicidin (29–41) as an adjunct to bone scan in differentiating infected versus noninfected loosening of prosthesis before revision surgery
Ajit Shinto(Kovai Medical Center and Hospital), Ashutosh Dash(Bhabha Atomic Research Centre), Jephy Joseph(Kovai Medical Center and Hospital), C. Arjun(Bhabha Atomic Research Centre), Aruna Korde(Bhabha Atomic Research Centre), Jyotsna Bhatt(Bhabha Atomic Research Centre), Kamalaeshwaran Koramadai Karuppusamy(Bhabha Atomic Research Centre), Indira V. Upadhya(Bhabha Atomic Research Centre), Grace Samuel, Archana Mukherjee(Bhabha Atomic Research Centre)
Cited by 15
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99